Enzolytics, Inc. (OTCMKTS:ENZC) Short Interest Update

Enzolytics, Inc. (OTCMKTS:ENZC) saw a large increase in short interest during the month of January. As of January 15th, there was short interest totalling 57,300 shares, an increase of 28,550.0% from the December 31st total of 200 shares. Based on an average daily trading volume, of 21,887,900 shares, the days-to-cover ratio is presently 0.0 days.

Enzolytics Stock Performance

Shares of OTCMKTS ENZC traded down $0.00 during mid-day trading on Tuesday, reaching $0.00. 10,299,364 shares of the company were exchanged, compared to its average volume of 5,525,667. Enzolytics has a twelve month low of $0.00 and a twelve month high of $0.02.

Enzolytics Company Profile

Enzolytics Inc, a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy.